GO:1905795 cellular response to puromycin: Protein Synthesis Stress Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905795 (cellular response to puromycin) describes how a cell changes its state or activity in response to puromycin, a tRNA-mimetic antibiotic that causes premature polypeptide chain termination and ribosome stalling.
• Puromycin incorporation into nascent polypeptides is widely used as a direct readout of global protein synthesis rates in cells and tissues.
• The cellular response to puromycin intersects with stress granule and P-body assembly, integrated stress response (ISR) signaling, and ubiquitin-proteasome system function.
• Puromycin-based selection and purification are used to establish pure cell populations, such as rat brain microvascular endothelial cells with improved barrier properties.
• Dysregulated translation and puromycin sensitivity are linked to cancer drug resistance, ER stress, and metabolic disease models.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes mediating the cellular response to puromycin.
Description
GO:1905795, cellular response to puromycin, is a biological process term that captures any change in a cell's state or activity — including movement, secretion, enzyme production, or gene expression — that occurs as a result of a puromycin stimulus. Puromycin is an aminonucleoside antibiotic that mimics aminoacyl-tRNA, binds the ribosomal A site, and becomes incorporated into nascent polypeptide chains, causing premature termination and ribosome stalling. Because this mechanism directly reports on translation, puromycin has become a cornerstone reagent for measuring protein synthesis in living cells and tissues. The cellular response to puromycin therefore encompasses both the immediate translational consequences of puromycin incorporation and the downstream adaptive signaling that cells mount to cope with stalled translation.
cellular response to puromycin At A Glance
| GO ID | GO:1905795 |
|---|---|
| GO term | cellular response to puromycin |
| Ontology | biological_process |
| Synonym | cellular response to 3'-deoxy-N,N-dimethyl-3'-(O-methyl-L-tyrosinamido)adenosine |
| Major function | Cellular adaptation to puromycin-induced translation inhibition and ribosome stalling |
| Related processes | Stress granule assembly, P-body assembly, integrated stress response, ubiquitin-proteasome system regulation |
| Key experimental readout | Puromycin incorporation measured by flow cytometry, western blot, or imaging |
| Disease relevance | Cancer drug resistance, ER stress, metabolic disease, endothelial barrier function |
What Is GO:1905795?
In our own words, GO:1905795 refers to the collection of cellular processes triggered when a cell encounters puromycin. The QuickGO definition states: Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a puromycin stimulus. This includes translational arrest, stress granule and P-body dynamics, activation of stress-responsive signaling, and changes in gene expression that help the cell manage puromycin-induced proteotoxic stress.
Why Is cellular response to puromycin Important in Cell Biology?
Understanding the cellular response to puromycin is important because puromycin is both a widely used tool for measuring translation and a perturbagen that reveals how cells sense and respond to ribosome dysfunction. This response is mechanistically coupled to stress granule and P-body assembly, ISR signaling, and proteasome function, making it a window into fundamental proteostasis networks. Clinically, genes that modulate puromycin sensitivity are implicated in platinum resistance in cancer and in ER stress-related β-cell apoptosis, underscoring the translational relevance of this process.
• Provides a direct functional readout of global protein synthesis rates in cells and tissues.
• Reveals how cells sense and adapt to ribosome stalling and premature termination.
• Connects translation stress to stress granule and P-body assembly.
• Links to integrated stress response and ubiquitin-proteasome system regulation.
• Used in puromycin-based selection to purify specialized cell populations such as brain microvascular endothelial cells.
• Relevant to cancer drug resistance mechanisms, including platinum resistance.
• Implicated in ER stress-mediated β-cell apoptosis in metabolic disease models.
• Enables study of cardiac hypertrophic growth and temporal translation dynamics.
• Supports drug discovery targeting translation and proteostasis pathways.
• Facilitates CRISPR-based causal gene validation in disease-relevant cell models.
What Happens During cellular response to puromycin?
Puromycin uptake and ribosomal incorporation
In simple terms: Puromycin enters the cell and tricks the ribosome into using it as a building block, which stops protein production.
Puromycin is an aminonucleoside antibiotic that structurally mimics aminoacyl-tRNA. Once inside the cell, it binds to the ribosomal A site and is incorporated into nascent polypeptide chains, causing premature chain termination and ribosome stalling. This incorporation event is the initiating stimulus for the cellular response to puromycin and is exploited experimentally to label newly synthesized proteins.
Translational arrest and ribosome quality control
In simple terms: When ribosomes stall, the cell activates quality control systems to deal with the jammed protein factories.
Puromycin-induced ribosome stalling triggers ribosome quality control pathways that detect and resolve stalled translation complexes. This response involves the ubiquitin-proteasome system, as chemical inhibition of the integrated stress response impairs the ubiquitin-proteasome system. The interplay between translation arrest and proteasome function is a key node in the cellular response to puromycin.
Stress granule and P-body assembly
In simple terms: The cell builds temporary storage compartments for stalled translation machinery.
tRNA synthetase activity is required for stress granule and P-body assembly, and puromycin treatment perturbs these dynamics. Stress granules and P-bodies are membraneless organelles that sequester stalled translation initiation complexes and mRNA, and their assembly is a hallmark of the cellular response to puromycin.
Integrated stress response and gene expression changes
In simple terms: The cell switches on a stress-response program that changes which genes are made into proteins.
The integrated stress response (ISR) is a signaling network that reprograms translation and gene expression under stress. Chemical inhibition of the ISR impairs the ubiquitin-proteasome system, linking ISR signaling to the cellular response to puromycin. Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation, demonstrating how translational control intersects with stress responses.
Downstream adaptive and maladaptive outcomes
In simple terms: Depending on the cell type, the response can protect the cell or push it toward death.
The cellular response to puromycin can lead to adaptive changes such as improved barrier properties in puromycin-purified endothelial cells, or maladaptive outcomes such as apoptosis under ER stress. In cancer, genes such as NPEPPS modulate platinum resistance, highlighting how puromycin-response pathways can influence drug sensitivity.
Key Genes Involved in GO:1905795 cellular response to puromycin
The following genes and proteins have been experimentally linked to the cellular response to puromycin, translation stress, and related proteostasis pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NPEPPS | Druggable driver of platinum resistance | Modulates drug sensitivity and translation stress responses |
| GPS2 | Inhibits K63 ubiquitination; regulates mitochondria-associated translation | Links ubiquitination to translation control |
| EIF2AK3 (PERK) | ER stress sensor kinase | Central to integrated stress response and translation inhibition |
| EIF2A | Translation initiation factor | Mediates ISR-dependent translation reprogramming |
| DDIT3 (CHOP) | Stress-induced transcription factor | Mediates ER stress-induced apoptosis |
| ATF4 | ISR effector transcription factor | Drives adaptive gene expression under translation stress |
| G3BP1 | Stress granule nucleator | Required for stress granule assembly |
| G3BP2 | Stress granule component | Contributes to stress granule dynamics |
| DDX6 | P-body component | Required for P-body assembly |
| EDC4 | P-body scaffold protein | Supports P-body formation |
| AARS1 | tRNA synthetase | Required for stress granule and P-body assembly |
| MARS1 | tRNA synthetase | Required for stress granule and P-body assembly |
| PSMD1 | Proteasome subunit | Links proteasome function to ISR |
| UBB | Ubiquitin precursor | Ubiquitin-proteasome system function |
| UBC | Ubiquitin precursor | Ubiquitin-proteasome system function |
| RPL10 | Ribosomal protein | Ribosome structure and stalling response |
| RPS6 | Ribosomal protein | Translation rate readout |
How Is cellular response to puromycin Regulated?
The cellular response to puromycin is regulated at multiple levels. The integrated stress response, centered on eIF2α phosphorylation, reprograms translation and is functionally coupled to the ubiquitin-proteasome system. tRNA synthetase activity is required for stress granule and P-body assembly, providing a regulatory link between aminoacylation and the puromycin response. Additionally, K63 ubiquitination regulated by GPS2 controls mitochondria-associated translation, adding a layer of ubiquitin-dependent regulation. Metformin can suppress β-cell apoptosis under ER stress by inhibiting protein translation, showing pharmacological modulation of this response.
cellular response to puromycin and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NPEPPS | Platinum resistance in cancer | Knockout and overexpression in cancer cell lines |
| EIF2AK3 | ER stress and β-cell apoptosis | Point mutation and knockout in β-cell models |
| GPS2 | Mitochondria-associated translation | Knockout and tagged knock-in in HeLa or HEK293 |
| G3BP1 | Stress granule assembly | Knockout and live-cell imaging |
| AARS1 | tRNA synthetase function | Knockout and rescue with point mutants |
Cancer drug resistance
NPEPPS is a druggable driver of platinum resistance, and its function intersects with translation stress pathways that are engaged by puromycin. This suggests that the cellular response to puromycin can inform strategies to overcome chemoresistance.
ER stress and metabolic disease
Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation, directly linking the cellular response to puromycin to metabolic disease mechanisms. Dysregulated translation contributes to β-cell loss in diabetes.
Endothelial barrier function
Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction, demonstrating that puromycin selection can enrich for cells with specialized barrier functions.
Cardiac hypertrophy
Temporal dynamics of cardiac hypertrophic growth in response to pressure overload involve changes in protein synthesis that can be monitored using puromycin incorporation. This connects the cellular response to puromycin to cardiovascular biology.
From cellular response to puromycin-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X causally regulate puromycin sensitivity? | CRISPR knockout in disease-relevant cell line |
| Does a disease-associated point mutation alter translation stress response? | CRISPR point mutation knock-in |
| Where does protein X localize during puromycin treatment? | Tagged knock-in with fluorescent tag |
| Does overexpression of gene Y protect against puromycin-induced apoptosis? | Doxycycline-inducible overexpression |
| Which genes mediate stress granule assembly under puromycin? | Genome-wide CRISPR library screening |
| How does puromycin incorporation change over time in tissue? | In vivo puromycin labeling and flow cytometry |
How to Study the cellular response to puromycin Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Puromycin incorporation flow cytometry | Global protein synthesis rate | Drug screening and translation studies |
| Ribosome profiling | Transcript-specific translation efficiency | Mechanistic studies of translation stress |
| RNA-seq | Gene expression changes | ISR target gene analysis |
| Proteomics | Protein abundance and modifications | Ubiquitin-proteasome system studies |
| Immunofluorescence | Stress granule and P-body formation | Organelle dynamics |
| Western blot | Puromycin-labeled protein levels | Tissue translation analysis |
| CRISPR library screening | Gene requirements for puromycin response | Functional genomics |
| Live-cell imaging | Real-time translation and organelle dynamics | Kinetic studies |
Puromycin incorporation assays
Puromycin incorporation into nascent polypeptides can be measured by flow cytometry using chemistry-based detection, providing a quantitative readout of global translation rates. This method is suitable for lymphoid cells and other suspension cultures.
Ribosome profiling and RNA-seq
Ribosome profiling captures ribosome-protected fragments to reveal transcript-specific translation changes during the cellular response to puromycin. RNA-seq complements this by measuring gene expression changes downstream of translation stress.
Proteomics and ubiquitin analysis
Mass spectrometry-based proteomics can quantify changes in protein abundance and ubiquitination status following puromycin treatment, linking the response to proteasome function.
Imaging of stress granules and P-bodies
Fluorescence microscopy of stress granule and P-body markers such as G3BP1 and DDX6 allows visualization of membraneless organelle dynamics during the cellular response to puromycin.
How CRISPR Can Be Used to Study GO:1905795 cellular response to puromycin
Knockout
CRISPR knockout of candidate genes such as NPEPPS or G3BP1 enables testing whether they are required for the cellular response to puromycin, including translation arrest and stress granule assembly.
Point Mutation
Point mutation knock-in can model disease-associated variants in genes like EIF2AK3 to determine how specific mutations alter puromycin sensitivity and ISR signaling.
Knock-in
Tagged knock-in of genes such as GPS2 or DDX6 allows visualization and immunoprecipitation of endogenous proteins during the puromycin response.
Overexpression
Overexpression of protective genes or dominant-negative constructs can test sufficiency for modulating puromycin-induced apoptosis and translation stress.
How EDITGENE Supports cellular response to puromycin Research
Researchers studying cellular response to puromycin-related genes often need to determine whether a candidate gene is causally involved in translation stress, stress granule assembly, or drug resistance. EDITGENE provides the CRISPR tools and services to build precisely engineered cell models for these questions.
Contact EDITGENE today to design your custom CRISPR model for cellular response to puromycin research.
Frequently Asked Questions About cellular response to puromycin
What is GO:1905795 cellular response to puromycin?
GO:1905795 is a Gene Ontology biological process term describing any change in a cell's state or activity as a result of a puromycin stimulus, including translation arrest and stress signaling.
What genes are involved in cellular response to puromycin?
Key genes include NPEPPS, GPS2, EIF2AK3, G3BP1, DDX6, and tRNA synthetases such as AARS1 and MARS1.
How is puromycin used to measure protein synthesis?
Puromycin is incorporated into nascent polypeptides and can be detected by flow cytometry or western blot to quantify global translation rates.
What happens to cells treated with puromycin?
Puromycin causes premature chain termination and ribosome stalling, leading to stress granule and P-body assembly, ISR activation, and possible apoptosis.
Is cellular response to puromycin related to cancer?
Yes, genes such as NPEPPS modulate platinum resistance, and translation stress pathways influence drug sensitivity.
What is the role of stress granules in puromycin response?
Stress granules sequester stalled translation complexes and require tRNA synthetase activity for assembly during puromycin treatment.
How does the integrated stress response relate to puromycin?
The ISR reprograms translation under stress, and its inhibition impairs the ubiquitin-proteasome system, linking it to puromycin responses.
Can CRISPR be used to study cellular response to puromycin?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of genes in this process.
What diseases are linked to puromycin response pathways?
Cancer drug resistance, ER stress-related β-cell apoptosis, and endothelial barrier dysfunction are linked to this process.
How do I choose a model to study cellular response to puromycin?
Select knockout for loss-of-function, point mutation for variant modeling, knock-in for tagging, and overexpression for gain-of-function studies.
Conclusion
GO:1905795 cellular response to puromycin is a biologically rich process that bridges translation control, stress signaling, and proteostasis. Its study has direct implications for cancer drug resistance, metabolic disease, and cardiovascular biology. By leveraging CRISPR-engineered cell models and quantitative translation assays, researchers can dissect the causal genes and mechanisms underlying this response.
References
- 1. Jones RT et al.. 2024. NPEPPS Is a Druggable Driver of Platinum Resistance.. Cancer Res 84(10):1699-1718 PMID: 38535994
- 2. Xu S et al.. 2024. Chemical inhibition of the integrated stress response impairs the ubiquitin-proteasome system.. Commun Biol 7(1):1282 PMID: 39379572
- 3. Gao Y et al.. 2024. Inhibition of K63 ubiquitination by G-Protein pathway suppressor 2 (GPS2) regulates mitochondria-associated translation.. Pharmacol Res 207:107336 PMID: 39094987
- 4. Kaul Z et al.. 2025. Method to Study Metabolism in Lymphoid Cells using Chemistry to Measure Puromycin Incorporation by Flow Cytometry.. J Vis Exp PMID: 40889248
- 5. Baymiller M et al.. 2026. tRNA synthetase activity is required for stress granule and P-body assembly.. Genes Dev 40(7-8):475-497 PMID: 41535071
- 6. Calabria AR et al.. 2006. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction.. J Neurochem 97(4):922-33 PMID: 16573646
- 7. Inoue R et al.. 2026. Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation.. Metabolism 180:156607 PMID: 41962652
- 8. Wang Y et al.. 2017. Temporal dynamics of cardiac hypertrophic growth in response to pressure overload.. Am J Physiol Heart Circ Physiol 313(6):H1119-H1129 PMID: 28822967
